Trial Search Results
Allo BMT in Advanced Leukemia or High Grade Lymphoma
To evaluate the role of ablative allogeneic hematopoietic cell transplantation in the treatment of advanced leukemia or lymphoma.
Stanford is currently not accepting patients for this trial.
- Procedure: ablative allogeneic hematopoietic cell transplantation
Inclusion Criteria:HLA identical donor
- adequate organ function
- other life threatening disease
Ages Eligible for Study
N/A - 50 Years
Genders Eligible for Study